These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6856535)

  • 1. Raynaud's phenomenon. Role of diet pills and cold remedies.
    Caperton E
    Postgrad Med; 1983 Jun; 73(6):291-2. PubMed ID: 6856535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The determination of the thermal threshold in subjects with Raynaud's disease. A preliminary report of 2 clinical cases].
    Luca S; Romeo S
    Minerva Cardioangiol; 1999 Jun; 47(6):213-7. PubMed ID: 10522147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive hyperemia in Raynaud's disease.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin-vinblastine associated Raynaud's phenomenon.
    Paty JG; Ruffner BW
    J Rheumatol; 1980; 7(6):927-8. PubMed ID: 6162955
    [No Abstract]   [Full Text] [Related]  

  • 11. Raynaud's phenomenon induced by sulphasalazine in a case of chronic ulcerative colitis.
    Ahmad J; Siddiqui MA; Khan AS; Afzall S
    J Assoc Physicians India; 1984 Apr; 32(4):370. PubMed ID: 6146597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Raynaud's phenomenon following treatment with cytostatics].
    Haastrup U; Storm TL
    Ugeskr Laeger; 1985 Dec; 147(49):4010. PubMed ID: 2418566
    [No Abstract]   [Full Text] [Related]  

  • 13. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome aberrations in Raynaud's phenomenon.
    Porciello G; Scarpato R; Storino F; Migliore L; Ferri C; Cagetti F; Morozzi G; Bellisai F; Marcolongo R; Galeazzi M
    Eur J Dermatol; 2004; 14(5):327-31. PubMed ID: 15358572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
    Pistorius MA; Planchon B; de Faucal P
    Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin-induced Raynaud's phenomenon.
    Kukla LJ; Burrows D; Bressler L; McGuire WP
    Arch Dermatol; 1981 Oct; 117(10):604. PubMed ID: 6169311
    [No Abstract]   [Full Text] [Related]  

  • 17. [The natural course of Raynaud's phenomenon].
    Clavijo F; Krahenbuhl B
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M; Izumi T; Kanoh H
    Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.